Harmony Biosciences to Participate in Three Investor Conferences in June

Rhea-AI Summary

Harmony Biosciences Holdings (Nasdaq: HRMY) announced participation in three upcoming investor conferences. President and CEO John Jacobs will host fireside chats at:

• Jefferies Healthcare Conference on June 2, 2021, at 2:30 PM ET
• Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021, at 3:50 PM ET
• Raymond James Human Health Innovation Conference on June 21, 2021, at 3:20 PM ET

Live webcasts will be available on Harmony's investor page. The company focuses on innovative therapies for rare neurological disorders.

PLYMOUTH MEETING, Pa., May 26, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, today announced that Harmony's President and CEO, John Jacobs, will participate in fireside chats and host investor meetings at the following upcoming virtual conferences:

• Jefferies Healthcare Conference
  Fireside Chat: June 2, 2:30pm ET
• Goldman Sachs 42^nd Annual Global Healthcare Conference
  Fireside Chat: June 10, 3:50pm ET
• Raymond James Human Health Innovation Conference
  Fireside Chat: June 21, 3:20pm ET

The live audio webcast of the fireside chats will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/. 

About Harmony Biosciences 
Harmony Biosciences is a pharmaceutical company headquartered in Plymouth Meeting, PA. The Company was established by Paragon Biosciences, LLC, with a vision to provide novel treatment options for people living with rare neurological disorders who have unmet medical needs. For more information on Harmony, please visit the company's website: www.harmonybiosciences.com.

Harmony Biosciences Investor Contact: 

Lisa Caperelli 
484-539-9736 
lcaperelli@harmonybiosciences.com 

Harmony Biosciences Media Contact: 

Nancy Leone 
215-891-6046 
nleone@harmonybiosciences.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-three-investor-conferences-in-june-301299307.html

SOURCE Harmony Biosciences

FAQ

What investor conferences is Harmony Biosciences attending in June 2021?

Harmony Biosciences is participating in the Jefferies Healthcare Conference on June 2, Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, and Raymond James Human Health Innovation Conference on June 21, 2021.

Who is the CEO of Harmony Biosciences?

The CEO of Harmony Biosciences is John Jacobs.

What is the focus of Harmony Biosciences?

Harmony Biosciences focuses on developing innovative therapies for patients with rare neurological disorders.

Where can I watch the fireside chats for Harmony Biosciences?

The fireside chats can be watched live on Harmony's investor page at https://ir.harmonybiosciences.com/.

What time is the Jefferies Healthcare Conference fireside chat?

The Jefferies Healthcare Conference fireside chat is scheduled for June 2, 2021, at 2:30 PM ET.